Elizabeth R. Gerstner

Massachusetts General Hospital — United States

Medicine · Health Sciences

59h-index18.2kcitations435works7.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(248), Radiomics and Machine Learning in Medical Imaging(83), Brain Metastases and Treatment(79), MRI in cancer diagnosis(64), Medical Imaging Techniques and Applications(44)

Publications433 total

Abstract PS3-04-28: Espwa: a deep learning-enabled computational pathology tool that facilitates precision oncology for haitian breast cancer patients
Clinical Cancer Research·2026
Prognostic significance of O6-methylguanine-DNA methyltransferase promoter methylation status in isocitrate dehydrogenase-mutant glioma
Neuro-Oncology·2025
Tumor-infiltrating lymphocyte therapy generated from melanoma brain metastasis: Proof-of-concept for CNS-derived cellular immunotherapy
Neuro-Oncology·2025
Supplementary Data 1 from Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma Patients
2025Open Access
CTNI-66. CERN 09-02: A PHASE 2 TRIAL OF CARBOPLATIN AND BEVACIZUMAB FOR RECURRENT ADULT EPENDYMOMA
Neuro-Oncology·2025Open Access
IMG-125. Differentiating tumor progression from pseudoprogression in glioma patients using MR elastography
Neuro-Oncology·2025Open Access
IMMU-38. Single-cell RNA sequencing of cerebrospinal fluid in CARv3-TEAM-E treated glioblastoma
Neuro-Oncology·2025Open Access
CTNI-30. ALLIANCE A071601: PHASE II TRIAL OF BRAF/MEK INHIBITION IN RECURRENT PAPILLARY CRANIOPHARYNGIOMAS
Neuro-Oncology·2025
IMG-21. Prognostic significance of contrast enhancement in newly diagnosed grade 2 <i>IDH</i> -mutant glioma
Neuro-Oncology·2025
EXTH-47. Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells
Neuro-Oncology·2025Open Access
CTNI-62. A SURGICAL WINDOW-OF-OPPORTUNITY TRIAL OF NIRAPARIB IN RECURRENT IDH-MUTANT GLIOMAS
Neuro-Oncology·2025Open Access
IMMU-58. Integrated multiomic profiling identifies genomic and immune microenvironmental changes as candidate resistance mechanisms to PD-1 blockade in high-grade meningiomas
Neuro-Oncology·2025Open Access
Limited evidence of pseudoprogression following immune checkpoint inhibitor (ICI) therapy in glioblastoma
Neuro-Oncology Advances·2025Open Access
ESPWA: a deep learning-enabled tool for precision-based use of endocrine therapy in resource-limited settings
2025Open Access
DSAI-03 DEEP LEARNING-BASED PREDICTION OF IMMUNE CHECKPOINT INHIBITOR EFFICACY IN BRAIN METASTASES USING BRAIN MRI
Neuro-Oncology Advances·2025Open Access
Abstract B023: Deep learning-based prediction of immune checkpoint inhibitor efficacy in brain metastases using brain MRI
Clinical Cancer Research·2025
Mesothelin is a surface antigen present on human meningioma and can be effectively targeted by CAR T-cells
Neuro-Oncology·2025· 4 citedOpen Access
Safety and tolerability of intraventricular CARv3-TEAM-E T cells following lymphodepleting chemotherapy in recurrent glioblastoma: INCIPIENT trial.
Journal of Clinical Oncology·2025· 2 cited
Enhancing precision oncology for Haitian breast cancer patients through deep learning-enabled computational pathology tools.
Journal of Clinical Oncology·2025
Immunological correlates from phase I study of CARv3-TEAM-E in patients with recurrent glioblastoma (GBM): INCIPIENT trial.
Journal of Clinical Oncology·2025
page 1 of 22Next →

Frequent Co-authors

Tracy T. Batchelor(28), Patrick Y. Wen(18), Daniel P. Cahill(10), Jayashree Kalpathy–Cramer(9), Bruce R. Rosen(9), Jörg Dietrich(9), Dan G. Duda(8), Rakesh K. Jain(8), Priscilla K. Brastianos(8), Evanthia Galanis(7), A. John Iafrate(7), Benjamin M. Ellingson(6), April F. Eichler(6), Ovidiu C. Andronesi(6), Scott R. Plotkin(5), Jay S. Loeffler(5), A. Gregory Sorensen(5), Kyrre E. Emblem(5), Naema Nayyar(5), Timothy J. Kaufmann(5)